• $667,148.00
    Market Cap
  • -9.09%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 55
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.0008
$0.001
$0.001
1-Year Range
$0.0007
$0.004
$0.001
Latest Close$0.001
Change
$0.00 (0.00%)
Volume785,198
Market Cap$667,148.00
Shares Outstanding691.3M
P/E (TTM)-1.21
Diluted EPS (TTM)-$0.0008
Enterprise Value$941,704.00

Information as of 06/03/2026

Company Profile

Pharmagreen Biotech Inc.
https://www.pharmagreen.ca
$667,148.00
Market Cap
-$310,265.00
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
2987 Blackbear Court, Coquitlam, BC, Canada, V3E 3A2
702 803 9404

Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.

Key Executives

  • Peter Wojcik
  • Terry Kwan

Current Ownership Distribution

  • Other691.3M (100.00%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)
  • Insiders0 (0.00%)